SCHEMBL883605

SCHEMBL883605

COC(=O)/C=C/c1n[nH]c2ccnc(OC3CCCCC3)c12

nearest known ligand 0.48

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 20/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766198 0.88 LRRK2 (0.48) LRRK2
SCHEMBL3766207 0.88 LRRK2 (0.48) LRRK2
SCHEMBL3774947 0.76 LRRK2 (0.59) LRRK2
SCHEMBL13006073 0.76 LRRK2 (0.59) LRRK2
SCHEMBL883213 0.75 LRRK2 (0.49) LRRK2
SCHEMBL13834181 0.75 LRRK2 (0.72) LRRK2
SCHEMBL883611 0.75 LRRK2 (0.72) LRRK2
SCHEMBL875542 0.74 LRRK2 (0.48) LRRK2
SCHEMBL13834169 0.74 LRRK2 (0.67) LRRK2
SCHEMBL883322 0.74 LRRK2 (0.67) LRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120295883-A1 COMPOUNDS GENENTECH, INC. (US) 2012-11-22 US disclosed
US-20120295883-A1 COMPOUNDS GENENTECH, INC. (US) 2012-11-22 US disclosed
WO-2012038743-A1 PYRAZOLOPYRIDINES AS INHIBITORS OF THE KINASE LRRK2 MEDICAL RESEARCH COUNCIL TECHNOLOGY (GB) 2012-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120295883-A1 COMPOUNDS ABCC5, PRNP, PC LRRK2 1512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.